Skip to content

Inter-Limb Transfer in Acute Stroke

Identifying Brain Regions Critical for Human Motor Learning Through Anatomic-functional Correlations of Deficits in Acute Stroke: Integrated Robotic and Voxel-based Lesion Symptom Mapping Approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07822633
Acronym
MLAS5
Enrollment
250
Registered
2026-09-16
Start date
2026-08-11
Completion date
2032-01-01
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke Patients, Healthy Individuals (Controls), Stroke, Acute, Stroke (Subacute)

Keywords

Motor Skill Learning, Upper limb, Acute stroke, Rehabilitation, Inter-limb transfer, Subacute stroke, Chronic stroke, Robotics

Brief summary

This study aims to investigate whether the improvements achieved through motor skill learning (MSkL) with the ipsilesional upper limb (UL) are transferred to the contralesional UL during the (sub)acute stroke phase, and to identify the neural substrates underlying this inter-limb transfer. To achieve this, healthy individuals, acute and chronic stroke patients will perform proximal and distal MSkL tasks using serious games implemented on robotic devices. This will be complemented by behavioural assessments and multimodal MRI.

Detailed description

Over 3 consecutive days, healthy individuals, acute and chronic stroke patients will be evaluated and will train on the rehabilitation robot REAplan® (http://www.axinesis.com/) to assess proximal MSkL and on the manual dexterity tool Dextrain Manipulandum (https://www.dextrain.com/) to assess distal MSkL. Healthy individuals, acute and chronic stroke patients will be randomised equally to 2 different groups. One group of participants will train over the 3 days on the serious game Circuit on the REAplan® and the game Targeting on the Dextrain Manipulandum. The other one will only be assessed on day 1 and day 3 on the serious games and will not have any training. For proximal upper limb with the serious game Circuit, the participants will have to practice a complex circuit and move a cursor as quickly and accurately as possible by controlling the handle of the robot. A Reaching task and a Drawing task will be used to assess motor control. For distal upper limb with the serious game Targeting, the participants will have to reach a series of targets with a cursor as quickly and accurately as possible by controlling their finger movements. To explore the role of different brain structures in inter-limb transfer, Voxel-based Lesion Symptom Mapping (VLSM) based on high-resolution brain magnetic resonance imaging (MRI) scans, will be used to analyse the relationship between tissue damage and inter-limb transfer scores on a voxel-by-voxel basis. Diffusion Tensor Imaging (DTI) will quantify the integrity of several white matter tracts, allowing through correlation analyses to unveil the white matter tracts crucial to achieve this transfer. Moreover, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions.

Interventions

DEVICEREAplan®

motor skill learning with the REAplan® rehabilitation robot, to be performed with ipsilesional arm

motor skill learning with the Dextrain Manipulandum® dexterity tool to be performed with ipsilesional hand

Sponsors

University Hospital of Mont-Godinne
Lead SponsorOTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Not aware being of the different versions of the tasks

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

ACUTE STROKE PATIENTS: Inclusion Criteria: * First acute ischemic or hemorrhagic stroke * Between the 2nd and 21st day post-stroke * Age: 40-90 years * Ability to complete the 3 consecutive sessions

Exclusion criteria

* Stroke with multiple brain lesions * Addiction (e.g., alcohol or drugs) * Pregnancy * Major cognitive impairment (e.g., depression, aphasia, dementia) * Inability to perform or understand the required tasks * Uncontrolled health conditions * " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophobia, etc ...) HEALTHY INDIVIDUALS: Inclusion Criteria: * 40-90 years * availability to complete three consecutive sessions.

Design outcomes

Primary

MeasureTime frameDescription
Speed/Accuracy Trade-off (SAT) measured by the REAplan® robotchange between baseline (Day 1) and after training (Day 3)Speed/Accuracy Trade-off: mathematical computation of the relationship between speed and accuracy
force measured by the REAplan® robotchange between baseline (Day 1) and after training (Day 3)forces exerted in the wrong direction by each arm (Newtons)
Root Mean Square Error (RMSE) measured by the Dextrain Manipulandumchange between baseline (Day 1) and after training (Day 3)error between the coordinates of the target and the cursor
Speed/Accuracy Trade-off (SAT) measured by the Dextrain Manipulandumchange between baseline (Day 1) and after training (Day 3)Speed/Accuracy Trade-off: mathematical computation of the relationship between speed and accuracy

Secondary

MeasureTime frameDescription
Hold time measured by the Dextrain Manipulandumchange between baseline (Day 1) and after training (Day 3)The amount of time the cursor remains inside the target zone
Coactivation measured by the Dextrain Manipulandumchange between baseline (Day 1) and after training (Day 3)binary measure of unasked fingers activated above the force threshold
Voxel-based Lesion Symptom Mapping (VLSM)BaselineDiffusion Weighted Imaging (DWI)
Diffusion Tensor Imaging (DTI)BaselineFractional Anisotropy
Fugl Meyer Upper Extremity Test (FMA-UE)Day1Tests impairments of the upper limb after stroke. Range: 0-66. A higher score means less impairment.
Oxford Cognitive Screen (OCS)Day2to identify cognitive impairments following stroke. Rather than providing only a single overall cognitive score, the OCS assesses several distinct cognitive domains (Language, Praxis, Number, Memory, Spatial and Controlled Attention) and produces a cognitive profile showing both preserved and impaired abilities.
Action Research Arm Test (ARAT)Day2evaluate upper-limb motor function and activity performance. Range: 0-57. higher scores indicating better upper-limb motor function
Fatigue Visual Analog Scale (VAS)Day 1Visual Analog Scale to evaluate fatigue = a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. Range : 0- 10. A higher score means a higher level of fatigue.
Intrinsic Motivation Inventory (IMI)Day3To assess participants' level of motivation and engagement in completing the proposed tasks. They will be asked to respond to a series of items concerning their interest in the activities, perceived competence, perceived effort, and the value they attribute to the task.
Box and Block Testchange between baseline (Day 1) and after training (Day 3)To assess gross manual dexterity and unilateral upper-limb function.The participant is asked to move as many small wooden blocks as possible from one compartment of a box to another within 60 seconds. The task is performed separately with each hand. Score range: 0-150 for each hand. The score corresponds to the number of blocks successfully transferred in one minute. A higher score indicates better gross manual dexterity and upper-limb function.
Speed, Accuracy and Speed/Accuracy Trade-off (SAT) measured by the REAplan® robot on a Reaching task and on a Drawing taskchange between baseline (Day 1) and after training (Day 3)A simple Reaching task and a Drawing task (mandala) to assess motor control on the REAplan(R) robot

Countries

Belgium

Contacts

CONTACTYves Vandermeeren, MD, PhD
yves.vandermeeren@uclouvain.be+32 81 42 33 21
CONTACTWumeng Wang, MSc
wumeng.wang@uclouvain.be
PRINCIPAL_INVESTIGATORYves Vandermeeren, MD,PhD

UCLouvain IONS

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026